Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nicolás Pavez P"'
Autor:
Rodrigo A. Cornejo, Jorge Montoya, Abraham I. J. Gajardo, Jerónimo Graf, Leyla Alegría, Romyna Baghetti, Anita Irarrázaval, César Santis, Nicolás Pavez, Sofía Leighton, Vinko Tomicic, Daniel Morales, Carolina Ruiz, Pablo Navarrete, Patricio Vargas, Roberto Gálvez, Victoria Espinosa, Marioli Lazo, Rodrigo A. Pérez-Araos, Osvaldo Garay, Patrick Sepúlveda, Edgardo Martinez, Alejandro Bruhn, the SOCHIMI Prone-COVID-19 Group
Publikováno v:
Annals of Intensive Care, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Background Prone positioning is currently applied in time-limited daily sessions up to 24 h which determines that most patients require several sessions. Although longer prone sessions have been reported, there is scarce evidence about the f
Externí odkaz:
https://doaj.org/article/1e6ec77e842e448892e858cec84cbdf9
Autor:
Ricardo Castro, Eduardo Kattan, Giorgio Ferri, Ronald Pairumani, Emilio Daniel Valenzuela, Leyla Alegría, Vanessa Oviedo, Nicolás Pavez, Dagoberto Soto, Magdalena Vera, César Santis, Brusela Astudillo, María Alicia Cid, Sebastian Bravo, Gustavo Ospina-Tascón, Jan Bakker, Glenn Hernández
Publikováno v:
Annals of Intensive Care, Vol 10, Iss 1, Pp 1-9 (2020)
Abstract Background Persistent hyperlactatemia has been considered as a signal of tissue hypoperfusion in septic shock patients, but multiple non-hypoperfusion-related pathogenic mechanisms could be involved. Therefore, pursuing lactate normalization
Externí odkaz:
https://doaj.org/article/c703c6dc6b764769a8025200493c3018
Publikováno v:
Revista chilena de pediatría v.84 n.3 2013
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Introducción: El tratamiento estándar de la Retinopatía del Prematuro (RDP) en etapa umbral es la fotocoagulación con láser (FCL). Recientemente se ha utilizado el bevacizumab, un inhibidor del factor de crecimiento del endotelio vascular (VEGF)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cb94a73f0aef77472f821629f53abda
https://doi.org/10.4067/s0370-41062013000300008
https://doi.org/10.4067/s0370-41062013000300008
Publikováno v:
Archivos Argentinos de Pediatria. 112
Ophthalmological outcomes in a series of children with retinopathy of prematurity (ROP) in the threshold stage treated with intravitreal bevacizumab are reported. Twelve very low birth weight (VLBW) preterm infants who were administered intravitreal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d718dbafc0914cc138017e5eb92c914
https://doi.org/10.5546/aap.2014.160
https://doi.org/10.5546/aap.2014.160
Publikováno v:
Archivos argentinos de pediatria. 112(2)
Ophthalmological outcomes in a series of children with retinopathy of prematurity (ROP) in the threshold stage treated with intravitreal bevacizumab are reported. Twelve very low birth weight (VLBW) preterm infants who were administered intravitreal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::836c6bc80d449b0f779e9a4f096b110a
https://pubmed.ncbi.nlm.nih.gov/24584791
https://pubmed.ncbi.nlm.nih.gov/24584791